Ajmal Khan
Impact in
- Organic Chemistry top 0.5%
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Click Chemistry and Applications
- Toxicology top 0.5%
Papers in
-
- Enzyme function and inhibition 52
- Natural product bioactivities and synthesis 26
-
- Synthesis and biological activity 68
- Synthesis and Characterization of Heterocyclic Compounds 26
- Co-authors
- Ahmed Al‐Harrasi (229 shared papers)Sobia Ahsan Halim (138 shared papers)M. Iqbal Choudhary (32 shared papers)Najeeb Ur Rehman (63 shared papers)Abdur Rauf (32 shared papers)Abdul Wadood (18 shared papers)Javid Hussain (44 shared papers)René Csük (34 shared papers)
- Journals
- Bioorganic Chemistry (21 papers)ACS Omega (19 papers)Medicinal Chemistry Research (15 papers)RSC Advances (11 papers)Scientific Reports (11 papers)
- Partner nations
- PakistanOmanSaudi Arabia
In The Last Decade
Ajmal Khan
368 papers receiving 6.8k citations
Ajmal Khan's Hit Papers
Peers
Comparison fields: 5 of 166
- Organic Chemistry 2.8k
- Toxicology 209
- Pharmacology 910
- Biochemistry 291
- Pharmacology 404
Countries citing papers authored by Ajmal Khan
This map shows the geographic impact of Ajmal Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajmal Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajmal Khan more than expected).
Fields of papers citing papers by Ajmal Khan
This network shows the impact of papers produced by Ajmal Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajmal Khan. The network helps show where Ajmal Khan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ajmal Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 390 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 283 | |
| 2 | 2014 | 108 | |
| 3 | 2022 | 95 | |
| 4 | 2014 | 95 | |
| 5 | 2018 | 86 | |
| 6 | 2021 | 85 | |
| 7 | 2015 | 84 | |
| 8 | 2019 | 83 | |
| 9 | 2010 | 82 | |
| 10 | 2022 | 80 | |
| 11 | 2015 | 79 | |
| 12 | 2010 | 77 | |
| 13 | 2017 | 76 | |
| 14 | Synthesis, molecular docking and DFT analysis of novel bis-Schiff base derivatives with thiobarbituric acid for α-glucosidase inhibition assessment Hit paper breakdown → | 2024 | 75 |
| 15 | 2017 | 72 | |
| 16 | 2019 | 63 | |
| 17 | 2015 | 63 | |
| 18 | 2019 | 61 | |
| 19 | 2022 | 60 | |
| 20 | 2010 | 60 |
About Ajmal Khan
Ajmal Khan is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Endocrinology, Diabetes and Metabolism and Plant Science, having authored 390 papers that have together received 7.0k indexed citations. Recurring topics across this work include Synthesis and biological activity (68 papers), Enzyme function and inhibition (52 papers), Natural Antidiabetic Agents Studies (46 papers), Microbial Applications in Construction Materials (40 papers), Computational Drug Discovery Methods (36 papers), Cholinesterase and Neurodegenerative Diseases (33 papers), Natural product bioactivities and synthesis (26 papers) and Synthesis and Characterization of Heterocyclic Compounds (26 papers). The work is most often cited by research in Organic Chemistry (2.8k citations), Toxicology (209 citations), Pharmacology (910 citations), Biochemistry (291 citations) and Pharmacology (404 citations). Ajmal Khan has collaborated with scholars based in Pakistan, Oman and Saudi Arabia. Frequent co-authors include Ahmed Al‐Harrasi, Sobia Ahsan Halim, M. Iqbal Choudhary, Najeeb Ur Rehman, Abdur Rauf, Abdul Wadood, Javid Hussain, René Csük, Umar Farooq and Imtiaz Khan. Their work appears in journals such as Bioorganic Chemistry, ACS Omega, Medicinal Chemistry Research, RSC Advances and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.